As of 2025-12-28, the Relative Valuation of Nova Mentis Life Science Corp (NOVA.CN) is (0.84) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Nova Mentis Life Science Corp based on Relative Valuation is -2194.5%.
The range of the Relative Valuation is (0.82) - (0.89) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.9x - 20.3x | 18.1x |
| Forward P/E multiples | 18.2x - 19.6x | 18.9x |
| Fair Price | (0.82) - (0.89) | (0.84) |
| Upside | -2158.3% - -2321.3% | -2194.5% |
| Date | P/E |